NCT03839966

Brief Summary

This study assesses whether a month long computerized interpretation bias modification intervention will reduce levels of loneliness compared to a control treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2019

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 11, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

January 29, 2021

Status Verified

January 1, 2021

Enrollment Period

1.3 years

First QC Date

February 11, 2019

Last Update Submit

January 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • UCLA Loneliness Scale (ULS)

    A 20 item Self report scale measuring loneliness. Scales range from 0 to 60 with higher scores indicating a higher level of loneliness.

    Change in loneliness from baseline to post treatment (4weeks) and three month follow up (16 weeks)

Secondary Outcomes (6)

  • Multidimensional Scale of Perceived Social Support

    Change in Perceived Social Support from baseline to post treatment (4weeks) and three month follow up (16 weeks)

  • Social Phobia inventory

    Change in social anxiety symptoms from baseline to post treatment (4 weeks) and three month follow up (16 weeks)

  • State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)

    Change in overall anxiety symptoms from baseline to post treatment (4 weeks) and three month follow up (16 weeks)

  • Center for Epidemiological Studies Depression Scale (CES-D)

    Change in depression symptoms from baseline to post treatment (4 weeks) and three month follow up (16 weeks)

  • Interpersonal Needs Questionnaire (INQ)

    Change in suicide vulnerability from baseline to post treatment (4 weeks) and three month follow up (16 weeks)

  • +1 more secondary outcomes

Study Arms (2)

Active Treatment

EXPERIMENTAL

Interpretation Bias Modification for Loneliness

Behavioral: Interpretation Bias Modification for Loneliness

Control Treatment

ACTIVE COMPARATOR

Healthy Habits Psychoeducation and Relaxation.

Behavioral: Healthy Habits Psychoeducation and Relaxation

Interventions

Participants will receive eight treatment sessions. They will be presented with ambiguous training scenarios on a computer screen. Scenarios will be presented in two discrete formats: a word-sentence relatedness task (adapted from Beard \& Amir, 2008 and Beard, Weisberg, \& Amir, 2011), and a sentence completion and comprehension task (adapted from paradigms used by Mathews and Mackintosh (2000), Steinman and Teachman (2010), and Beard and Amir (2008)). Both of these formats have been used to reduce maladaptive threat interpretations and increase benign interpretations.

Active Treatment

Participants will receive eight computerized sessions consisting of psychoeducation on healthy behaviors as well as relaxing video clips with pleasant music (e.g., videos of rainforests, wildlife, and space). These sessions will be matched for time with the active condition, lasting approximately 25-30 minutes each. Psychoeducation will cover the topics of exercise, diet, hygiene, social support, healthy activities, and sleep. The relaxing videos will be presented after the psycho-education in each session. At the conclusion of the study, participants will be provided with the active IBM treatment free of charge if they wish to receive it.

Control Treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Score of \>48 on the UCLA Loneliness Scale

You may not qualify if:

  • Concurrent psychotherapy for social anxiety or depression
  • Unstable psychotropic medication status (i.e. a change within the last month)
  • History of psychotic or (hypo)manic symptoms
  • Alcohol or other substance abuse or dependence within the last three months
  • Previous participation in a similar IBM study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University, Department of Psychology

Tallahassee, Florida, 32306, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not know if they are receiving the active or control treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized to receive one of two treatments
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 11, 2019

First Posted

February 15, 2019

Study Start

January 25, 2019

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

January 29, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations